2020
DOI: 10.1016/j.lwt.2020.109544
|View full text |Cite
|
Sign up to set email alerts
|

Caffeoylquinic acids from aronia juice inhibit both dipeptidyl peptidase IV and α-glucosidase activities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 33 publications
1
7
0
Order By: Relevance
“…Another way to improve glucose tolerance in diabetic patients is by enhancing the glucose-regulating hormones, namely glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) [ 83 ]. Dipeptidyl peptidase-IV (DPP-IV) is the enzyme responsible for the degradation of GLP-1, GIP [ 84 ], and gliptins, such as sitagliptin, vildagliptin, saxagliptin, alogliptin, linagliptin, gemigliptin, and teneligliptin, which are commercialized in the USA, Europe, Japan, and Korea as DPP-IV inhibitors [ 85 ].…”
Section: Resultsmentioning
confidence: 99%
“…Another way to improve glucose tolerance in diabetic patients is by enhancing the glucose-regulating hormones, namely glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) [ 83 ]. Dipeptidyl peptidase-IV (DPP-IV) is the enzyme responsible for the degradation of GLP-1, GIP [ 84 ], and gliptins, such as sitagliptin, vildagliptin, saxagliptin, alogliptin, linagliptin, gemigliptin, and teneligliptin, which are commercialized in the USA, Europe, Japan, and Korea as DPP-IV inhibitors [ 85 ].…”
Section: Resultsmentioning
confidence: 99%
“…Apart from α-glucosidase, dipeptidyl peptidase IV (DPP IV), which could inactivate intestinal peptide glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP), plays a crucial role in type 2 diabetes mellitus. 153 A study by Imai et al 154 demonstrated that 3-CQA (2) and 4-CQA (6) possessed inhibitory activity against DPP IV, with IC 50 values of 0.19 and 0.05 μM, respectively.…”
Section: Biological Activities Of Natural Cqasmentioning
confidence: 99%
“…Furthermore, in preclinical studies, CQAs are able to inhibit α‐glucosidase and were proposed to mitigate the incidence of so‐called lifestyle‐related diseases, such as diabetes (Imai et al. , 2020). Every day, we ingest CQAs from plant‐derived food, including fruits and vegetables.…”
Section: Introductionmentioning
confidence: 99%